Group One Trading’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
Other funds holding RGC
Group One Trading's RGC Position: Q3 2026 in Review
Group One Trading reduced its Regencell Bioscience (RGC) stake by 70% in Q3 2026, selling an estimated $3.88K and leaving 283 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #7015.
Group One Trading first reported a position in RGC in Q3 2025 and has held it in 4 quarters since. The position peaked at $9K in Q1 2026. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.
- Group One Trading held 283 shares of Regencell Bioscience worth $1.76K as of Q3 2026.
- Group One Trading sold 670 Regencell Bioscience shares in Q3 2026, an estimated $3.88K.
- Regencell Bioscience made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7015 holding.
- Group One Trading first reported a position in Regencell Bioscience in Q3 2025 and has held it in 4 quarters since.
- Group One Trading's Regencell Bioscience position peaked at $9K in Q1 2026.
- 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.